biology - Page 13
Stories from biology come first, newest first, then stories from connected topics (genomics, AI for science, AI Science & Health, drug discovery, Biotech, Hub: Tech for Good), each labelled with where it comes from. This view is not indexed by search engines.
Latest
Scripps Research Gets Over 14 Million GPU Hours From Huang Foundation
Scripps Research gets more than 14 million GPU hours from the Huang Foundation via CoreWeave/NVIDIA. In-kind; no dollar value.
Johns Hopkins-Led Team Wins Up to $52.1m to Model Protein Misfolding
Johns Hopkins leads an ARPA-H award of up to $52.1m over four years for an open protein-misfolding AI model, starting with Parkinson’s and Ewing sarcoma.
CERN and Mistral Sign Intent to Build a Large Physics Model
CERN and Mistral signed a statement of intent to develop a Large Physics Model for collider physics. The model is not built yet; no timeline disclosed.
China Proposes Adding 40 AI, Biomedicine and Solar Technologies to Its Export-Control Catalogue
China's commerce and science ministries propose adding 40 AI, biomedicine and solar technologies to the export-control catalogue, with registration now.
Google DeepMind Shows Its Antigravity Agent Finding a New Antimicrobial Peptide Candidate, Which Still Needs Lab Testing
Google DeepMind says its Antigravity agent helped find a new antimicrobial peptide candidate. It is a computational lead now in lab testing.
Sanofi Options First Development Candidate From Its Recursion AI Collaboration
Sanofi has optioned a potential first-in-class oral immunology candidate from Recursion, triggering a $10m milestone. Phase 1 is planned for 2027.
insitro and AstraZeneca Sign AI Collaboration to Hunt Drugs for MASH and Cardiomyopathies
insitro gets $40m upfront and is eligible for up to about $1.46bn in potential milestones in an AstraZeneca AI deal for MASH and heart disease.
NVIDIA Pledges Tools and Compute to the EU’s AI in Science Enablers
NVIDIA joined the European Commission's AI in Science Enablers initiative at the Dublin summit, pledging tools, compute and training for researchers.
Deep Origin and BioAge Labs Team Up on AI Drug Discovery, With First Hits Confirmed in the Lab
Deep Origin says its AI found drug hits against a new BioAge Labs target that BioAge has confirmed in the lab, in a new multi-target collaboration.
Baker Lab Uses AI to Design Enzymes That Cut Specific Proteins
Two Nature papers from David Baker's lab describe AI-designed enzymes that cut chosen proteins, including ones linked to disease. They are not treatments.
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.
